FINAXIONResearch
Finaxion Research · ICT / Smart Money: the fair value gap · single stocks · Recomputed 2026-09-10

Does ICT / Smart Money: the fair value gap work on CHRW?

ICT / Smart Money: the fair value gap does not beat buy-and-hold on CHRW: -16.0 points a year over 29 years.

Total return
-44.4%
Buy and hold
×44
CAGR
-2.0%
Sharpe
-1.17
Max drawdown
-49.0%
Trades
166
Out of sample
overfit
Years
29
10×61×1998200120042007201020132016201920222025
StrategyCHRW

Findings

  1. ICT / Smart Money: the fair value gap does not beat buy-and-hold on CHRW: -16.0 points a year over 29 years.
  2. Against the S&P 500 over the same window: -11.4 points a year.
  3. Total return -44.4% versus ×44 for buy-and-hold, with 166 trades.
  4. The result does not hold out of sample: it is overfit.
  5. Maximum drawdown -49.0%.
  6. It beats in neither half of the history (split at 2012).
  7. It ranks #134 of 235 markets for this strategy by annual excess over the S&P 500.

Findings derived from the full panel. Each carries its number and its denominator; the computations are reproducible with artifact baf59d3a43e0.

Exactly what was tested

Mechanical approximation: three-candle bullish gaps are detected within a 38-bar window; a return of price into the gap → entry; exit after 20 bars.

How to read it

The verdict compares the strategy with buying and holding CHRW over the same window, with round-trip costs per asset class. “Out of sample” is walk-forward: the rule is fit on one stretch and judged on the next. A result that beats in the full sample but not out of it is overfit. Full methodology in the protocol. How we test.

Open this backtest with its trades   Trades (CSV)

Every strategy on CHRW → · Full page for ICT / Smart Money: the fair value gap →

How to cite

Finaxion Research (2026). Does ICT / Smart Money: the fair value gap work on CHRW?. Daily backtest 1962-01-01–2026-08-31, artifact baf59d3a43e0. https://finaxion.app/en/research/ict-fair-value-gap/chrw

Not a recommendation. Past performance does not guarantee future results.